Concepedia

Author

Andra Cīrule

Riga East University Hospital

Also Known As

A. Cirule, Andra Cirule, Andra Cīrule, Lawrence J. Geiter, Vija Riekstina

17

Publications

1.4K

Citations

10

H-Index

13

Concepts

All Affiliations

Riga East University HospitalUniversity of LatviaUniversity College LondonTartu University HospitalTuBerculosis Vaccine Initiative
AC

About

Andra Cīrule is an author at Riga East University Hospital specializing in disease progression, tuberculosis diagnostics, and antimicrobial resistance.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

11

2

Epidemiology

1

1

11

3

Pharmacology

1

1

11

4

Drug Discovery

1

1

11

5

Drug Resistance

1

1

11

Andra Cīrule

×

7

Publications

645

Citations

7

H-Index

YearCitations

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis

Vija Skripconoka, Manfred Danilovitš, Lea Pehme,

European Respiratory Journal

2012

336

Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial

Florian von Groote-Bidlingmaier, R. F. Patientia, Epifanio Sánchez,

The Lancet Respiratory Medicine

2019

161

ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update

Giovanni Battista Migliori, Giovanni Sotgiu, Senia Rosales-Klintz,

European Respiratory Journal

2018

85

Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia

Helen R. Stagg, Peter J White, Vija Riekstiņa,

Emerging infectious diseases

2016

25

Effect of NAT2, GSTM1 and CYP2E1 genetic polymorphisms on plasma concentration of isoniazid and its metabolites in patients with tuberculosis, and the assessment of exposure-response relationships

Viktorija Ulanova, Agnija Kivrāne, Anda Vīksna,

Frontiers in Pharmacology

2024

14

LC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma: Implications for therapeutic drug monitoring

Agnija Kivrāne, Solveiga Grı̄nberga, Eduards Sevostjanovs,

Journal of Chromatography B

2021

13

Drug Susceptibility Patterns in MDR-TB Patients: Challenges for Future Regimen Design. A Cross-Sectional Study

Helen R. Stagg, James Brown, Elmira Ibraim,

PLoS ONE

2015

11

Page 1